Even though this result was consistent with the requirement for GRIP1 in the IFN pathway, a pronounced IFN signature in mice with more severe pathology argues against type I IFN serving a solely protective role in EAE/MS. The gene discussed is GRIP1; the disease is myeloid sarcoma.